Shortcutting Drug Development- Economic Benefits Of Using Genome-Wide Association Studies (Gwas) To Reposition Existing Drugs To Other Therapeutic Areas
May 1, 2014, 00:00
10.1016/j.jval.2014.03.162
https://www.valueinhealthjournal.com/article/S1098-3015(14)00213-7/fulltext
Title :
Shortcutting Drug Development- Economic Benefits Of Using Genome-Wide Association Studies (Gwas) To Reposition Existing Drugs To Other Therapeutic Areas
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00213-7&doi=10.1016/j.jval.2014.03.162
First page :
A26
Section Title :
Health Care Use and Policy Studies
Open access? :
No
Section Order :
996